InMed enters $10M standby equity facility with Yorkville; shares at 97% of VWAP

InMed Pharmaceuticals Inc.

Up to $10M common shares may be sold to YA II PN, Ltd (Yorkville) at 97% of lowest daily VWAP over 3-day pricing period.
Facility runs until Jan 1, 2027 (~36 months); issuance capped at 19.99% of outstanding (unless pricing conditions met).
Company pays $25k structuring fee plus 2.50% commitment fee ($250k) – 25% cash upfront, 75% deferred quarterly.
Proceeds for working capital and general corporate purposes; CEO cites flexibility and extended runway.
Sales at company's discretion; no obligation to sell any shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.